Pancreatic Cancer Research

ResearcherAsan Medical CenterNo recent work listed

Sora Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3847-4442; OpenAlex author ID A5032395169. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2022: 1 paper

Papers 1

  1. Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/17588359221097190↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ki Byung Song · 1 shared paper, 2022 · strength 0.12
  2. Kyu‐pyo Kim · 1 shared paper, 2022 · strength 0.12
  3. Sarang Hong · 1 shared paper, 2022 · strength 0.12
  4. Do Hyun Park · 1 shared paper, 2022 · strength 0.12
  5. Jin‐hong Park · 1 shared paper, 2022 · strength 0.12
  6. Dae Wook Hwang · 1 shared paper, 2022 · strength 0.12
  7. Tae Jun Song · 1 shared paper, 2022 · strength 0.12
  8. Woohyung Lee · 1 shared paper, 2022 · strength 0.12
  9. Bong Jun Kwak · 1 shared paper, 2022 · strength 0.12
  10. So Heun Lee · 1 shared paper, 2022 · strength 0.12
  11. Dong Wan Seo · 1 shared paper, 2022 · strength 0.12
  12. Baek‐Yeol Ryoo · 1 shared paper, 2022 · strength 0.12
  13. Changhoon Yoo · 1 shared paper, 2022 · strength 0.12
  14. Sang Soo Lee · 1 shared paper, 2022 · strength 0.12
  15. Dongwook Oh · 1 shared paper, 2022 · strength 0.12
  16. Song Cheol Kim · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.